Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.83 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | AHR | P35869 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | HTR2A | P28223 | 1/20 | 0.59 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.59 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27929625 | 0.91 | GPR84 (1.00) | GPR84MEN1KMT2AAHRCYP3A4 | |
| SCHEMBL31744620 | 0.88 | GPR84 (0.73) | GPR84MEN1KMT2AAHRCYP3A4 | |
| SCHEMBL31744818 | 0.88 | GPR84 (0.73) | GPR84MEN1KMT2AAHRCYP3A4 | |
| SCHEMBL31744810 | 0.87 | GPR84 (0.78) | GPR84MEN1KMT2AAHRCYP3A4 | |
| SCHEMBL31744782 | 0.86 | GPR84 (0.71) | GPR84MEN1KMT2AAHRCYP3A4 | |
| SCHEMBL31744842 | 0.86 | GPR84 (0.76) | GPR84MEN1KMT2AAHRCYP3A4 | |
| SCHEMBL28547448 | 0.85 | GPR84 (0.75) | GPR84MEN1KMT2AAHRCYP3A4 | |
| SCHEMBL31744668 | 0.84 | GPR84 (0.73) | GPR84MEN1KMT2AAHRCYP3A4 | |
| SCHEMBL31744805 | 0.84 | GPR84 (0.73) | GPR84MEN1KMT2AAHRCYP3A4 | |
| SCHEMBL28841869 | 0.84 | GPR84 (0.62) | GPR84MEN1KMT2AAHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | claimed |
| US-20250382269-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CFD RES CORPORATION (US) | 2025-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382269-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CD14, MIF, NOD2 | GPR84 4183/4885MEN1 2402/4885KMT2A 4633/4885 |
| US-20250382268-A1 | METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | CD14, MIF, NOD2 | GPR84 4183/4885MEN1 2402/4885KMT2A 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.